Veterinary active pharmaceutical ingredients manufacturing are made by more than one reaction from raw materials. It generally becomes an active pharmaceutical ingredients through the chemical compounds. The active pharmaceutical ingredients manufacturing utilize specific standards for determining how strong it is in every drug.

This report aims to provide a comprehensive study of the global market for Veterinary Active Pharmaceutical Ingredients Manufacturing.
Report Highlights:

(1) Global Veterinary Active Pharmaceutical Ingredients Manufacturing market size (value), history data from 2018-2022 and forecast data from 2023 to 2029.

(2) Global Veterinary Active Pharmaceutical Ingredients Manufacturing market competitive situation, revenue and market share, from 2018 to 2022.

(3) China Veterinary Active Pharmaceutical Ingredients Manufacturing market competitive situation, revenue and market share, from 2018 to 2022.

(4) Global Veterinary Active Pharmaceutical Ingredients Manufacturing segment by region (or country), key regions cover the United States, Europe, Japan, South Korea, Southeast Asia and India, etc.

(5) Global Veterinary Active Pharmaceutical Ingredients Manufacturing segment by type and by application and regional segment by type and by application.

(6) Veterinary Active Pharmaceutical Ingredients Manufacturing industry supply chain, upstream, midstream and downstream analysis.

According to Latest Research, the global market for Veterinary Active Pharmaceutical Ingredients Manufacturing should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.

China Veterinary Active Pharmaceutical Ingredients Manufacturing market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.

The United States Veterinary Active Pharmaceutical Ingredients Manufacturing market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.

In terms of type, Antiparasitic segment holds a share about % in 2022 and will reach % in 2029; while in terms of application, Companion Animals has a share approximately % in 2022 and will grow at a CAGR % during 2023 and 2029.

The global key manufacturers of Veterinary Active Pharmaceutical Ingredients Manufacturing include Alivira Animal Health Ltd., Chempro Pharma Private Ltd., Excel Industries Ltd., FIS - Fabbrica Italiana Sintetici S.p.A., HIKAL Ltd., HuBei Masteam Bio-tech, Hunan Huateng Pharmaceutical, Jiangsu Rivocean and Ofichem Group, etc. In 2022, the global top five players hold a share approximately % in terms of revenue.

Market segment by regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)

South America (Brazil, Rest of South America)

Middle East & Africa

By Product Type, the market is primarily segmented into:

Antiparasitic

Anti-infectives

NSAIDs

Others

By Applications, the market is segmented into:

Companion Animals

Production/Food Animals

Key Players Driving the Market:

Alivira Animal Health Ltd.

Chempro Pharma Private Ltd.

Excel Industries Ltd.

FIS - Fabbrica Italiana Sintetici S.p.A.

HIKAL Ltd.

HuBei Masteam Bio-tech

Hunan Huateng Pharmaceutical

Jiangsu Rivocean

Ofichem Group

Qilu Pharma Spain, S.A.

Menadiona

Nissan Chemical

SUANFARMA

Siflon Drugs

Shaanxi Dideu Group

Taizhou Crene Biotechnology

Zhejiang Gihi Chemicals

Vetpharma (Insud Pharma, S.L.U)

1 Market Overview

1.1 Product Overview and Scope of Veterinary Active Pharmaceutical Ingredients Manufacturing

1.2 Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size and Forecast

1.3 China Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size and Forecast

1.4 China Market Percentage in Global

1.4.1 By Revenue, China Veterinary Active Pharmaceutical Ingredients Manufacturing Share in Global Market, 2018-2029

1.4.2 Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size: China VS Global, 2018-2029

1.5 Veterinary Active Pharmaceutical Ingredients Manufacturing Market Dynamics

1.5.1 Veterinary Active Pharmaceutical Ingredients Manufacturing Market Drivers

1.5.2 Veterinary Active Pharmaceutical Ingredients Manufacturing Market Restraints

1.5.3 Veterinary Active Pharmaceutical Ingredients Manufacturing Industry Trends

1.5.4 Veterinary Active Pharmaceutical Ingredients Manufacturing Industry Policy

2 Global Competitive Situation by Company

2.1 Global Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue by Company (2018-2023)

2.2 Global Veterinary Active Pharmaceutical Ingredients Manufacturing Participants, Market Position (Tier 1, Tier 2 and Tier 3)

2.3 Global Veterinary Active Pharmaceutical Ingredients Manufacturing Concentration Ratio

2.4 Global Veterinary Active Pharmaceutical Ingredients Manufacturing Mergers & Acquisitions, Expansion Plans

2.5 Global Veterinary Active Pharmaceutical Ingredients Manufacturing Manufacturers Product Type

3 China Competitive Situation by Company

3.1 China Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue by Company (2018-2023)

3.2 China Veterinary Active Pharmaceutical Ingredients Manufacturing Veterinary Active Pharmaceutical Ingredients Manufacturing Participants, Market Position (Tier 1, Tier 2 and Tier 3)

3.3 China Veterinary Active Pharmaceutical Ingredients Manufacturing, Revenue Percentage of Local Players VS Foreign Manufacturers (2018-2023)

4 Industry Chain Analysis

4.1 Veterinary Active Pharmaceutical Ingredients Manufacturing Industry Chain

4.2 Veterinary Active Pharmaceutical Ingredients Manufacturing Upstream Analysis

4.3 Veterinary Active Pharmaceutical Ingredients Manufacturing Midstream Analysis

4.4 Veterinary Active Pharmaceutical Ingredients Manufacturing Downstream Analysis

5 Sights by Type

5.1 Veterinary Active Pharmaceutical Ingredients Manufacturing Classification

5.1.1 Antiparasitic

5.1.2 Anti-infectives

5.1.3 NSAIDs

5.1.4 Others

5.2 By Type, Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size & CAGR, 2018 VS 2022 VS 2029

5.3 By Type, Global Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue, 2018-2029

6 Sights by Application

6.1 Veterinary Active Pharmaceutical Ingredients Manufacturing Segment by Application

6.1.1 Companion Animals

6.1.2 Production/Food Animals

6.2 By Application, Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size & CAGR, 2018 VS 2022 VS 2029

6.3 By Application, Global Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue, 2018-2029

7 Sales Sights by Region

7.1 By Region, Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size, 2018 VS 2022 VS 2029

7.2 By Region, Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size, 2018-2029

7.3 North America

7.3.1 North America Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size & Forecasts, 2018-2029

7.3.2 By Country, North America Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size Market Share

7.4 Europe

7.4.1 Europe Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size & Forecasts, 2018-2029

7.4.2 By Country, Europe Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size Market Share

7.5 Asia Pacific

7.5.1 Asia Pacific Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size & Forecasts, 2018-2029

7.5.2 By Country/Region, Asia Pacific Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size Market Share

7.6 South America

7.6.1 South America Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size & Forecasts, 2018-2029

7.6.2 By Country, South America Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size Market Share

7.7 Middle East & Africa

8 Sights by Country Level

8.1 By Country, Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size & CAGR，2018 VS 2022 VS 2029

8.2 By Country, Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size, 2018-2029

8.3 U.S.

8.3.1 U.S. Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size, 2018-2029

8.3.2 By Company, U.S. Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue Market Share, 2018-2023

8.3.3 By Type, U.S. Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue Market Share, 2022 VS 2029

8.3.4 By Application, U.S. Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue Market Share, 2022 VS 2029

8.4 Europe

8.4.1 Europe Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size, 2018-2029

8.4.2 By Company, Europe Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue Market Share, 2018-2023

8.4.3 By Type, Europe Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue Market Share, 2022 VS 2029

8.4.4 By Application, Europe Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue Market Share, 2022 VS 2029

8.5 China

8.5.1 China Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size, 2018-2029

8.5.2 By Company, China Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue Market Share, 2018-2023

8.5.3 By Type, China Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue Market Share, 2022 VS 2029

8.5.4 By Application, China Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue Market Share, 2022 VS 2029

8.6 Japan

8.6.1 Japan Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size, 2018-2029

8.6.2 By Company, Japan Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue Market Share, 2018-2023

8.6.3 By Type, Japan Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue Market Share, 2022 VS 2029

8.6.4 By Application, Japan Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue Market Share, 2022 VS 2029

8.7 South Korea

8.7.1 South Korea Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size, 2018-2029

8.7.2 By Company, South Korea Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue Market Share, 2018-2023

8.7.3 By Type, South Korea Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue Market Share, 2022 VS 2029

8.7.4 By Application, South Korea Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue Market Share, 2022 VS 2029

8.8 Southeast Asia

8.8.1 Southeast Asia Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size, 2018-2029

8.8.2 By Company, Southeast Asia Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue Market Share, 2018-2023

8.8.3 By Type, Southeast Asia Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue Market Share, 2022 VS 2029

8.8.4 By Application, Southeast Asia Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue Market Share, 2022 VS 2029

8.9 India

8.9.1 India Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size, 2018-2029

8.9.2 By Company, India Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue Market Share, 2018-2023

8.9.3 By Type, India Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue Market Share, 2022 VS 2029

8.9.4 By Application, India Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue Market Share, 2022 VS 2029

8.10 Middle East & Asia

8.10.1 Middle East & Asia Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size, 2018-2029

8.10.2 By Company, Middle East & Asia Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue Market Share, 2018-2023

8.10.3 By Type, Middle East & Asia Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue Market Share, 2022 VS 2029

8.10.4 By Application, Middle East & Asia Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue Market Share, 2022 VS 2029

9 Global Manufacturers Profile

9.1 Alivira Animal Health Ltd.

9.1.1 Alivira Animal Health Ltd. Company Information, Head Office, Market Area and Industry Position

9.1.2 Alivira Animal Health Ltd. Company Profile and Main Business

9.1.3 Alivira Animal Health Ltd. Veterinary Active Pharmaceutical Ingredients Manufacturing Models, Specifications and Application

9.1.4 Alivira Animal Health Ltd. Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue and Gross Margin, 2018-2023

9.1.5 Alivira Animal Health Ltd. Recent Developments

9.2 Chempro Pharma Private Ltd.

9.2.1 Chempro Pharma Private Ltd. Company Information, Head Office, Market Area and Industry Position

9.2.2 Chempro Pharma Private Ltd. Company Profile and Main Business

9.2.3 Chempro Pharma Private Ltd. Veterinary Active Pharmaceutical Ingredients Manufacturing Models, Specifications and Application

9.2.4 Chempro Pharma Private Ltd. Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue and Gross Margin, 2018-2023

9.2.5 Chempro Pharma Private Ltd. Recent Developments

9.3 Excel Industries Ltd.

9.3.1 Excel Industries Ltd. Company Information, Head Office, Market Area and Industry Position

9.3.2 Excel Industries Ltd. Company Profile and Main Business

9.3.3 Excel Industries Ltd. Veterinary Active Pharmaceutical Ingredients Manufacturing Models, Specifications and Application

9.3.4 Excel Industries Ltd. Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue and Gross Margin, 2018-2023

9.3.5 Excel Industries Ltd. Recent Developments

9.4 FIS - Fabbrica Italiana Sintetici S.p.A.

9.4.1 FIS - Fabbrica Italiana Sintetici S.p.A. Company Information, Head Office, Market Area and Industry Position

9.4.2 FIS - Fabbrica Italiana Sintetici S.p.A. Company Profile and Main Business

9.4.3 FIS - Fabbrica Italiana Sintetici S.p.A. Veterinary Active Pharmaceutical Ingredients Manufacturing Models, Specifications and Application

9.4.4 FIS - Fabbrica Italiana Sintetici S.p.A. Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue and Gross Margin, 2018-2023

9.4.5 FIS - Fabbrica Italiana Sintetici S.p.A. Recent Developments

9.5 HIKAL Ltd.

9.5.1 HIKAL Ltd. Company Information, Head Office, Market Area and Industry Position

9.5.2 HIKAL Ltd. Company Profile and Main Business

9.5.3 HIKAL Ltd. Veterinary Active Pharmaceutical Ingredients Manufacturing Models, Specifications and Application

9.5.4 HIKAL Ltd. Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue and Gross Margin, 2018-2023

9.5.5 HIKAL Ltd. Recent Developments

9.6 HuBei Masteam Bio-tech

9.6.1 HuBei Masteam Bio-tech Company Information, Head Office, Market Area and Industry Position

9.6.2 HuBei Masteam Bio-tech Company Profile and Main Business

9.6.3 HuBei Masteam Bio-tech Veterinary Active Pharmaceutical Ingredients Manufacturing Models, Specifications and Application

9.6.4 HuBei Masteam Bio-tech Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue and Gross Margin, 2018-2023

9.6.5 HuBei Masteam Bio-tech Recent Developments

9.7 Hunan Huateng Pharmaceutical

9.7.1 Hunan Huateng Pharmaceutical Company Information, Head Office, Market Area and Industry Position

9.7.2 Hunan Huateng Pharmaceutical Company Profile and Main Business

9.7.3 Hunan Huateng Pharmaceutical Veterinary Active Pharmaceutical Ingredients Manufacturing Models, Specifications and Application

9.7.4 Hunan Huateng Pharmaceutical Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue and Gross Margin, 2018-2023

9.7.5 Hunan Huateng Pharmaceutical Recent Developments

9.8 Jiangsu Rivocean

9.8.1 Jiangsu Rivocean Company Information, Head Office, Market Area and Industry Position

9.8.2 Jiangsu Rivocean Company Profile and Main Business

9.8.3 Jiangsu Rivocean Veterinary Active Pharmaceutical Ingredients Manufacturing Models, Specifications and Application

9.8.4 Jiangsu Rivocean Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue and Gross Margin, 2018-2023

9.8.5 Jiangsu Rivocean Recent Developments

9.9 Ofichem Group

9.9.1 Ofichem Group Company Information, Head Office, Market Area and Industry Position

9.9.2 Ofichem Group Company Profile and Main Business

9.9.3 Ofichem Group Veterinary Active Pharmaceutical Ingredients Manufacturing Models, Specifications and Application

9.9.4 Ofichem Group Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue and Gross Margin, 2018-2023

9.9.5 Ofichem Group Recent Developments

9.10 Qilu Pharma Spain, S.A.

9.10.1 Qilu Pharma Spain, S.A. Company Information, Head Office, Market Area and Industry Position

9.10.2 Qilu Pharma Spain, S.A. Company Profile and Main Business

9.10.3 Qilu Pharma Spain, S.A. Veterinary Active Pharmaceutical Ingredients Manufacturing Models, Specifications and Application

9.10.4 Qilu Pharma Spain, S.A. Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue and Gross Margin, 2018-2023

9.10.5 Qilu Pharma Spain, S.A. Recent Developments

9.11 Menadiona

9.11.1 Menadiona Company Information, Head Office, Market Area and Industry Position

9.11.2 Menadiona Company Profile and Main Business

9.11.3 Menadiona Veterinary Active Pharmaceutical Ingredients Manufacturing Models, Specifications and Application

9.11.4 Menadiona Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue and Gross Margin, 2018-2023

9.11.5 Menadiona Recent Developments

9.12 Nissan Chemical

9.12.1 Nissan Chemical Company Information, Head Office, Market Area and Industry Position

9.12.2 Nissan Chemical Company Profile and Main Business

9.12.3 Nissan Chemical Veterinary Active Pharmaceutical Ingredients Manufacturing Models, Specifications and Application

9.12.4 Nissan Chemical Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue and Gross Margin, 2018-2023

9.12.5 Nissan Chemical Recent Developments

9.13 SUANFARMA

9.13.1 SUANFARMA Company Information, Head Office, Market Area and Industry Position

9.13.2 SUANFARMA Company Profile and Main Business

9.13.3 SUANFARMA Veterinary Active Pharmaceutical Ingredients Manufacturing Models, Specifications and Application

9.13.4 SUANFARMA Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue and Gross Margin, 2018-2023

9.13.5 SUANFARMA Recent Developments

9.14 Siflon Drugs

9.14.1 Siflon Drugs Company Information, Head Office, Market Area and Industry Position

9.14.2 Siflon Drugs Company Profile and Main Business

9.14.3 Siflon Drugs Veterinary Active Pharmaceutical Ingredients Manufacturing Models, Specifications and Application

9.14.4 Siflon Drugs Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue and Gross Margin, 2018-2023

9.14.5 Siflon Drugs Recent Developments

9.15 Shaanxi Dideu Group

9.15.1 Shaanxi Dideu Group Company Information, Head Office, Market Area and Industry Position

9.15.2 Shaanxi Dideu Group Company Profile and Main Business

9.15.3 Shaanxi Dideu Group Veterinary Active Pharmaceutical Ingredients Manufacturing Models, Specifications and Application

9.15.4 Shaanxi Dideu Group Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue and Gross Margin, 2018-2023

9.15.5 Shaanxi Dideu Group Recent Developments

9.16 Taizhou Crene Biotechnology

9.16.1 Taizhou Crene Biotechnology Company Information, Head Office, Market Area and Industry Position

9.16.2 Taizhou Crene Biotechnology Company Profile and Main Business

9.16.3 Taizhou Crene Biotechnology Veterinary Active Pharmaceutical Ingredients Manufacturing Models, Specifications and Application

9.16.4 Taizhou Crene Biotechnology Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue and Gross Margin, 2018-2023

9.16.5 Taizhou Crene Biotechnology Recent Developments

9.17 Zhejiang Gihi Chemicals

9.17.1 Zhejiang Gihi Chemicals Company Information, Head Office, Market Area and Industry Position

9.17.2 Zhejiang Gihi Chemicals Company Profile and Main Business

9.17.3 Zhejiang Gihi Chemicals Veterinary Active Pharmaceutical Ingredients Manufacturing Models, Specifications and Application

9.17.4 Zhejiang Gihi Chemicals Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue and Gross Margin, 2018-2023

9.17.5 Zhejiang Gihi Chemicals Recent Developments

9.18 Vetpharma (Insud Pharma, S.L.U)

9.18.1 Vetpharma (Insud Pharma, S.L.U) Company Information, Head Office, Market Area and Industry Position

9.18.2 Vetpharma (Insud Pharma, S.L.U) Company Profile and Main Business

9.18.3 Vetpharma (Insud Pharma, S.L.U) Veterinary Active Pharmaceutical Ingredients Manufacturing Models, Specifications and Application

9.18.4 Vetpharma (Insud Pharma, S.L.U) Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue and Gross Margin, 2018-2023

9.18.5 Vetpharma (Insud Pharma, S.L.U) Recent Developments

10 Conclusion

11 Appendix

11.1 Research Methodology

11.2 Data Source

11.2.1 Secondary Sources

11.2.2 Primary Sources

11.3 Market Estimation Model

11.4 Disclaimer

Table 1. Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size & CAGR: China VS Global, (US$ Million), 2018-2029

Table 2. Veterinary Active Pharmaceutical Ingredients Manufacturing Market Restraints

Table 3. Veterinary Active Pharmaceutical Ingredients Manufacturing Market Trends

Table 4. Veterinary Active Pharmaceutical Ingredients Manufacturing Industry Policy

Table 5. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue by Company (2018-2023) & (US$ million)

Table 6. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue Market Share by Company (2018-2023)

Table 7. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Manufacturers Market Concentration Ratio (CR3 and HHI)

Table 8. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Mergers & Acquisitions, Expansion Plans

Table 9. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Manufacturers Product Type

Table 10. China Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue by Company (2018-2023) & (US$ million)

Table 11. China Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue Market Share by Company (2018-2023)

Table 12. Global Key Players of Veterinary Active Pharmaceutical Ingredients Manufacturing Upstream (Raw Materials)

Table 13. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Typical Customers

Table 14. Veterinary Active Pharmaceutical Ingredients Manufacturing Typical Distributors

Table 15. By Type, Global Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million

Table 16. By Application, Global Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million

Table 17. By Region, Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size, 2018 VS 2022 VS 2029, US$ Million

Table 18. By Region, Global Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue, 2018-2029, US$ Million

Table 19. By Country, Global Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue & CAGR，2018 VS 2022 VS 2029, US$ Million

Table 20. By Country, Global Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue, 2018-2029, US$ Million

Table 21. By Country, Global Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue Market Share, 2018-2029

Table 22. Alivira Animal Health Ltd. Company Information, Head Office, Market Area and Industry Position

Table 23. Alivira Animal Health Ltd. Company Profile and Main Business

Table 24. Alivira Animal Health Ltd. Veterinary Active Pharmaceutical Ingredients Manufacturing Models, Specifications and Application

Table 25. Alivira Animal Health Ltd. Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue and Gross Margin, 2018-2023

Table 26. Alivira Animal Health Ltd. Recent Developments

Table 27. Chempro Pharma Private Ltd. Company Information, Head Office, Market Area and Industry Position

Table 28. Chempro Pharma Private Ltd. Company Profile and Main Business

Table 29. Chempro Pharma Private Ltd. Veterinary Active Pharmaceutical Ingredients Manufacturing Models, Specifications and Application

Table 30. Chempro Pharma Private Ltd. Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue and Gross Margin, 2018-2023

Table 31. Chempro Pharma Private Ltd. Recent Developments

Table 32. Excel Industries Ltd. Company Information, Head Office, Market Area and Industry Position

Table 33. Excel Industries Ltd. Company Profile and Main Business

Table 34. Excel Industries Ltd. Veterinary Active Pharmaceutical Ingredients Manufacturing Models, Specifications and Application

Table 35. Excel Industries Ltd. Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue and Gross Margin, 2018-2023

Table 36. Excel Industries Ltd. Recent Developments

Table 37. FIS - Fabbrica Italiana Sintetici S.p.A. Company Information, Head Office, Market Area and Industry Position

Table 38. FIS - Fabbrica Italiana Sintetici S.p.A. Company Profile and Main Business

Table 39. FIS - Fabbrica Italiana Sintetici S.p.A. Veterinary Active Pharmaceutical Ingredients Manufacturing Models, Specifications and Application

Table 40. FIS - Fabbrica Italiana Sintetici S.p.A. Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue and Gross Margin, 2018-2023

Table 41. FIS - Fabbrica Italiana Sintetici S.p.A. Recent Developments

Table 42. HIKAL Ltd. Company Information, Head Office, Market Area and Industry Position

Table 43. HIKAL Ltd. Company Profile and Main Business

Table 44. HIKAL Ltd. Veterinary Active Pharmaceutical Ingredients Manufacturing Models, Specifications and Application

Table 45. HIKAL Ltd. Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue and Gross Margin, 2018-2023

Table 46. HIKAL Ltd. Recent Developments

Table 47. HuBei Masteam Bio-tech Company Information, Head Office, Market Area and Industry Position

Table 48. HuBei Masteam Bio-tech Company Profile and Main Business

Table 49. HuBei Masteam Bio-tech Veterinary Active Pharmaceutical Ingredients Manufacturing Models, Specifications and Application

Table 50. HuBei Masteam Bio-tech Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue and Gross Margin, 2018-2023

Table 51. HuBei Masteam Bio-tech Recent Developments

Table 52. Hunan Huateng Pharmaceutical Company Information, Head Office, Market Area and Industry Position

Table 53. Hunan Huateng Pharmaceutical Company Profile and Main Business

Table 54. Hunan Huateng Pharmaceutical Veterinary Active Pharmaceutical Ingredients Manufacturing Models, Specifications and Application

Table 55. Hunan Huateng Pharmaceutical Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue and Gross Margin, 2018-2023

Table 56. Hunan Huateng Pharmaceutical Recent Developments

Table 57. Jiangsu Rivocean Company Information, Head Office, Market Area and Industry Position

Table 58. Jiangsu Rivocean Company Profile and Main Business

Table 59. Jiangsu Rivocean Veterinary Active Pharmaceutical Ingredients Manufacturing Models, Specifications and Application

Table 60. Jiangsu Rivocean Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue and Gross Margin, 2018-2023

Table 61. Jiangsu Rivocean Recent Developments

Table 62. Ofichem Group Company Information, Head Office, Market Area and Industry Position

Table 63. Ofichem Group Company Profile and Main Business

Table 64. Ofichem Group Veterinary Active Pharmaceutical Ingredients Manufacturing Models, Specifications and Application

Table 65. Ofichem Group Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue and Gross Margin, 2018-2023

Table 66. Ofichem Group Recent Developments

Table 67. Qilu Pharma Spain, S.A. Company Information, Head Office, Market Area and Industry Position

Table 68. Qilu Pharma Spain, S.A. Company Profile and Main Business

Table 69. Qilu Pharma Spain, S.A. Veterinary Active Pharmaceutical Ingredients Manufacturing Models, Specifications and Application

Table 70. Qilu Pharma Spain, S.A. Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue and Gross Margin, 2018-2023

Table 71. Qilu Pharma Spain, S.A. Recent Developments

Table 72. Menadiona Company Information, Head Office, Market Area and Industry Position

Table 73. Menadiona Company Profile and Main Business

Table 74. Menadiona Veterinary Active Pharmaceutical Ingredients Manufacturing Models, Specifications and Application

Table 75. Menadiona Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue and Gross Margin, 2018-2023

Table 76. Menadiona Recent Developments

Table 77. Nissan Chemical Company Information, Head Office, Market Area and Industry Position

Table 78. Nissan Chemical Company Profile and Main Business

Table 79. Nissan Chemical Veterinary Active Pharmaceutical Ingredients Manufacturing Models, Specifications and Application

Table 80. Nissan Chemical Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue and Gross Margin, 2018-2023

Table 81. Nissan Chemical Recent Developments

Table 82. SUANFARMA Company Information, Head Office, Market Area and Industry Position

Table 83. SUANFARMA Company Profile and Main Business

Table 84. SUANFARMA Veterinary Active Pharmaceutical Ingredients Manufacturing Models, Specifications and Application

Table 85. SUANFARMA Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue and Gross Margin, 2018-2023

Table 86. SUANFARMA Recent Developments

Table 87. Siflon Drugs Company Information, Head Office, Market Area and Industry Position

Table 88. Siflon Drugs Company Profile and Main Business

Table 89. Siflon Drugs Veterinary Active Pharmaceutical Ingredients Manufacturing Models, Specifications and Application

Table 90. Siflon Drugs Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue and Gross Margin, 2018-2023

Table 91. Siflon Drugs Recent Developments

Table 92. Shaanxi Dideu Group Company Information, Head Office, Market Area and Industry Position

Table 93. Shaanxi Dideu Group Company Profile and Main Business

Table 94. Shaanxi Dideu Group Veterinary Active Pharmaceutical Ingredients Manufacturing Models, Specifications and Application

Table 95. Shaanxi Dideu Group Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue and Gross Margin, 2018-2023

Table 96. Shaanxi Dideu Group Recent Developments

Table 97. Taizhou Crene Biotechnology Company Information, Head Office, Market Area and Industry Position

Table 98. Taizhou Crene Biotechnology Company Profile and Main Business

Table 99. Taizhou Crene Biotechnology Veterinary Active Pharmaceutical Ingredients Manufacturing Models, Specifications and Application

Table 100. Taizhou Crene Biotechnology Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue and Gross Margin, 2018-2023

Table 101. Taizhou Crene Biotechnology Recent Developments

Table 102. Zhejiang Gihi Chemicals Company Information, Head Office, Market Area and Industry Position

Table 103. Zhejiang Gihi Chemicals Company Profile and Main Business

Table 104. Zhejiang Gihi Chemicals Veterinary Active Pharmaceutical Ingredients Manufacturing Models, Specifications and Application

Table 105. Zhejiang Gihi Chemicals Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue and Gross Margin, 2018-2023

Table 106. Zhejiang Gihi Chemicals Recent Developments

Table 107. Vetpharma (Insud Pharma, S.L.U) Company Information, Head Office, Market Area and Industry Position

Table 108. Vetpharma (Insud Pharma, S.L.U) Company Profile and Main Business

Table 109. Vetpharma (Insud Pharma, S.L.U) Veterinary Active Pharmaceutical Ingredients Manufacturing Models, Specifications and Application

Table 110. Vetpharma (Insud Pharma, S.L.U) Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue and Gross Margin, 2018-2023

Table 111. Vetpharma (Insud Pharma, S.L.U) Recent Developments

List of Figure

Figure 1. Veterinary Active Pharmaceutical Ingredients Manufacturing Picture

Figure 2. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Industry Market Size and Forecast (US$ million) & (2018-2029)

Figure 3. China Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue and Forecast (US$ million) & (2018-2029)

Figure 4. 2018-2029 China Veterinary Active Pharmaceutical Ingredients Manufacturing Market Share of Global

Figure 5. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Key Participants, Market Share, 2021 VS 2022 VS 2023

Figure 6. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market Share by Company, (Tier 1, Tier 2 and Tier 3), 2018-2023

Figure 7. China Veterinary Active Pharmaceutical Ingredients Manufacturing Key Participants, Market Share, 2021 VS 2022 VS 2023

Figure 8. China Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue, Domestic VS Import Products, Proportion of China Local Players and Foreign Players, 2018-2023

Figure 9. Veterinary Active Pharmaceutical Ingredients Manufacturing Industry Chain

Figure 10. Antiparasitic

Figure 11. Anti-infectives

Figure 12. NSAIDs

Figure 13. Others

Figure 14. By Type, Global Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue, 2018-2029, US$ Million

Figure 15. By Type, Global Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue Market Share, 2018-2029

Figure 16. Companion Animals

Figure 17. Production/Food Animals

Figure 18. By Application, Global Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue, 2018-2029, US$ Million

Figure 19. By Application, Global Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue Market Share, 2018-2029

Figure 20. By Region, Global Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue Market Share, 2018-2029

Figure 21. North America Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue & Forecasts, 2018-2029, US$ Million

Figure 22. By Country, North America Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue Market Share, 2018-2023

Figure 23. Europe Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue & Forecasts, 2018-2029, US$ Million

Figure 24. By Country, Europe Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue Market Share, 2018-2023

Figure 25. Asia Pacific Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue & Forecasts, 2018-2029, US$ Million

Figure 26. By Country/Region, Asia Pacific Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue Market Share, 2018-2023

Figure 27. South America Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue & Forecasts, 2018-2029, US$ Million

Figure 28. By Country, South America Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue Market Share, 2018-2023

Figure 29. Middle East & Africa Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue & Forecasts, 2018-2029, US$ Million

Figure 30. U.S. Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue, 2018-2029, (US$ Million)

Figure 31. By Company, U.S. Veterinary Active Pharmaceutical Ingredients Manufacturing Market Share, 2018-2023

Figure 32. By Type, U.S. Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue Market Share, 2022 VS 2029

Figure 33. By Application, U.S. Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue Market Share, 2022 VS 2029

Figure 34. Europe Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue, 2018-2029, (US$ Million)

Figure 35. By Company, Europe Veterinary Active Pharmaceutical Ingredients Manufacturing Market Share, 2018-2023

Figure 36. By Type, Europe Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue Market Share, 2022 VS 2029

Figure 37. By Application, Europe Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue Market Share, 2022 VS 2029

Figure 38. China Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue, 2018-2029, (US$ Million)

Figure 39. By Company, China Veterinary Active Pharmaceutical Ingredients Manufacturing Market Share, 2018-2023

Figure 40. By Type, China Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue Market Share, 2022 VS 2029

Figure 41. By Application, China Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue Market Share, 2022 VS 2029

Figure 42. Japan Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue, 2018-2029, (US$ Million)

Figure 43. By Company, Japan Veterinary Active Pharmaceutical Ingredients Manufacturing Market Share, 2018-2023

Figure 44. By Type, Japan Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue Market Share, 2022 VS 2029

Figure 45. By Application, Japan Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue Market Share, 2022 VS 2029

Figure 46. South Korea Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue, 2018-2029, (US$ Million)

Figure 47. By Company, South Korea Veterinary Active Pharmaceutical Ingredients Manufacturing Market Share, 2018-2023

Figure 48. By Type, South Korea Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue Market Share, 2022 VS 2029

Figure 49. By Application, South Korea Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue Market Share, 2022 VS 2029

Figure 50. Southeast Asia Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue, 2018-2029, (US$ Million)

Figure 51. By Company, Southeast Asia Veterinary Active Pharmaceutical Ingredients Manufacturing Market Share, 2018-2023

Figure 52. By Type, Southeast Asia Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue Market Share, 2022 VS 2029

Figure 53. By Application, Southeast Asia Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue Market Share, 2022 VS 2029

Figure 54. India Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue, 2018-2029, (US$ Million)

Figure 55. By Company, India Veterinary Active Pharmaceutical Ingredients Manufacturing Market Share, 2018-2023

Figure 56. By Type, India Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue Market Share, 2022 VS 2029

Figure 57. By Application, India Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue Market Share, 2022 VS 2029

Figure 58. Middle East & Asia Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue, 2018-2029, (US$ Million)

Figure 59. By Company, Middle East & Asia Veterinary Active Pharmaceutical Ingredients Manufacturing Market Share, 2018-2023

Figure 60. By Type, Middle East & Asia Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue Market Share, 2022 VS 2029

Figure 61. By Application, Middle East & Asia Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue Market Share, 2022 VS 2029

Figure 62. Research Methodology

Figure 63. Breakdown of Primary Interviews

Figure 64. Bottom-up Approaches

Figure 65. Top-down Approaches

Methodology/Research Approach

This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.

Research Programs/Design

Historical Data (2015-2019)	Industry Trends Competitive Landscape By Company Expansion Mergers and Acquisitions Market Segment by Type by Application By Regions/ Geography	Value Status and Outlook Value for Major Players Market Share Growth Rate Present Situation Analysis Value Market Share Growth Rate Present Situation Analysis
Influencing Factors	Market Environment Government Policy Technological Changes Market Risks	Market Drivers Growing Demand of Downstream Reduction in Cost
Market Forecast (2021-2026)	Overall Size by Type by Application By Regions/Geography	Key Data (Value) Market Share Growth Rate CAGR (2021-2026)

Market Size Estimation

Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).

The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.

Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.

All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report

The following figure shows an illustrative representation of the overall market size estimation process used for this study.

Market Breakdown and Data Triangulation

After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.

Data Source

Secondary Sources

Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.

Market Size	Segmental value Geographic Penetration Product Adoption Rate for Different market	Journals, Websites, and Press Releases Annual Reports and SEC Filings Company Websites and Press Releases Public and Paid Databases Market Intellix Data Repository
Market Position of Top Company	Product Financials Geographic value Mix Total Company value Business/Segmental value Mix
Qualitative Analysis	Influence Factors Market Potential Market Risks and Opportunities Industry Trends Geographical Features Government Policies	Company Websites and Press Releases Public and Paid Databases Annual Reports Industry Associations Market Intellix Data Repository

Primary Sources

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.

Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.

Key Executives Interviewed

Key Data Information from Primary Sources

Primary Sources	Parameters	Key Data
Market Segments(by Application, by Type)	Value by Type Status and Forecast Value by Application Value by Regions, Status and Forecast (2021-2026)	Value Market Share by Type Value Growth Rate by Type Value by Application Percentage and Growth Rate by Application Value Growth Rate and Market Share by Regions Market Size Status and Forecast (2021-2026)
Total Market	Overall Size, Status and Forecast	Market Size Status and Forecast (2021-2026)